glp-1 receptor agonist atrial fibrillation risk Impact of Therapy on Recurrence After Catheter Ablation in Obese Patients: A Real-World Data Analysis GLP‑1 Therapy Improves Atrial Fibrillation

*** Use of sustained-release glucocorticoid formulations may result in detectable glucocorticoid levels past the washout period due to prolonged systemic absorption

Providers increasingly encounter patients Read More Protecting Muscle While Treating Obesity: New Protein Targets for Older Adults on GLP-1s Jun 16, 2026 Articles, Diet and Nutrition, Exercise, Geriatric Medicine, GLP- 1 Agonist Therapy Center, GLP-1 Agonist Therapy Center, Obesity, Obesity 1,502 views The rise of highly effective GLP-1 receptor agonists and dual incretin therapies has transformed obesity treatment

Probiotic Clostridium butyricum ameliorated motor deficits in a mouse model of Parkinson's disease via gut microbiota-GLP-1 pathway

Additionally, there is a lower incidence of hypoglycemia with GLP-1 RAs compared to prandial insulin

doi: 10.1111/bpa.12402 69 Perez OrtizJMSwerdlowRH

Further, it is anticipated that 635 million people have impaired glucose tolerance, while 488 million have impaired fasting glucose